Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

MolecularHUB Gives Scientific Information on Fast-moving Diseases

Published: Thursday, October 25, 2012
Last Updated: Thursday, October 25, 2012
Bookmark and Share
A scientific gateway website that will provide molecular and genetic information on infectious and emerging diseases has been released by Purdue University.

The MolecularHUB site was announced Wednesday (Oct. 24) at the annual meeting of the Association for Molecular Pathology (AMP), which is being held in Long Beach, Calif.

James McGlothlin, a Purdue associate professor of health sciences and director of the site, said MolecularHUB will actively foster an environment of co-creation and collaboration. The goal of the site is to expand the current knowledge base of genetic markers, gene sequencing and molecular testing related to infectious diseases, chronic diseases and emerging diseases to help speed the identification and treatment of these diseases.

"With this site we have the opportunity to improve public health care and patient outcomes by providing free, easy access to the latest information," McGlothlin said. "The half-life of information in this field is very short; it's one of the fastest moving disciplines in modern science. So this site will keep professionals up-to-date with the latest scientific information."

The site, http://www.molecularHUB.org, is exclusively sponsored by BD (Becton Dickinson and Company), a Fortune 500 medical supply company.

"The goal is involve anyone working with molecular diagnostics so we can combine and leverage resources and capabilities," McGlothlin said. "This will allow us to standardize work practices and provide training and programs that will enhance scientific knowledge in this field."

Gregory Meehan, vice president for diagnostic systems and molecular diagnostics at BD Diagnostics, one of three divisions of BD, said the site has the potential to bring together medical and scientific communities.

"The valuable information and experiences of the global laboratory, scientific and academic community will come together through MolecularHUB in developing and sharing best practices across the spectrum of molecular-based diagnostic applications, laboratory efficiency, and clinical and economic outcomes," Meehan said.

The site is built on the Purdue-developed platform HUBzero, which has been used by more than 40 scientific, engineering and medical gateway sites as resources for scientific communities.

"MolecularHUB will be accessible to the more than 600,000 visitors of other hubs each year," McGlothlin said. "This will foster other opportunities for synergistic collaborations among disciplines such as engineering, laboratory design and ergonomics, and drug delivery."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Friday, April 22, 2016
Zika Virus Structure Revealed
Team at Purdue becomes the first to determine the structure of the Zika virus, which reveals insights critical to the development of effective antiviral treatments and vaccines.
Monday, April 04, 2016
New Technique Yields Drug, Biomedical Test Results in One Minute
Slug flow microextraction makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine.
Tuesday, October 14, 2014
Purdue, Houston Methodist to Take Drug Discoveries from the Bench Top to the Bedside
The planned collaboration on research and educational initiatives includes clinical trials of drugs developed at Purdue.
Monday, March 17, 2014
Purdue to Accelerate Drug Discovery, Development
Purdue Center for Drug Discovery adds to Purdue's strengths and the capacity to translate basic research into life-changing treatments.
Monday, September 16, 2013
New Imaging Technology Could Reveal Cellular Secrets
Researchers have married two biological imaging technologies, creating a new way to learn how good cells go bad.
Friday, April 26, 2013
Yeast Study Yields Potential for New Cholesterol, Anti-Fungal Drugs
While studying a mutant strain of yeast, Purdue University researchers may have found a new target for drugs to combat cholesterol and fungal diseases.
Thursday, February 28, 2013
Gene's function May Give New Target for Cancer Drugs
Scientists have determined that a gene long known to be involved in cancer cell formation and chemotherapy resistance is key to proper RNA creation, and could one day lead to new therapies and drug targets.
Thursday, September 13, 2012
Biochip Helps Study Living Cells
The biochip could speed scientific research, which could accelerate drug development for muscle and nerve disorders.
Friday, November 10, 2006
Scientific News
Drugs that May Combat Deadly Antibiotic-Resistant Bacteria Uncovered
Study identifies 79 compounds that inhibit carbapenem-resistant Enterobacteriaceae (CRE).
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!